Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARBEAU A. The pathogenesis of Parkinson's disease: a new hypothesis. Can Med Assoc J. 1962 Oct 13;87:802–807. [PMC free article] [PubMed] [Google Scholar]
- BIRKMAYER W., HORNYKIEWICZ O. [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. Wien Klin Wochenschr. 1961 Nov 10;73:787–788. [PubMed] [Google Scholar]
- GREER M., WILLIAMS C. M. Dopamine metabolism in Parkinson's disease. Neurology. 1963 Jan;13:73–76. doi: 10.1212/wnl.13.1.73. [DOI] [PubMed] [Google Scholar]
- GRODEN B. M. Parkinsonism occurring with methyldopa treatment. Br Med J. 1963 Apr 13;1(5336):1001–1001. doi: 10.1136/bmj.1.5336.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HORNYKIEWICZ O. [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease]. Wien Klin Wochenschr. 1963 May 3;75:309–312. [PubMed] [Google Scholar]
- MCGEER P. L., ZELDOWICZ L. R. ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS. Can Med Assoc J. 1964 Feb 15;90:463–466. [PMC free article] [PubMed] [Google Scholar]
- PEASTON M. J. PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY. Br Med J. 1964 Jul 18;2(5402):168–168. doi: 10.1136/bmj.2.5402.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PRESCOTT L. F. METHYLDOPA AND PARKINSONISM. Br Med J. 1964 Sep 12;2(5410):687–687. doi: 10.1136/bmj.2.5410.687-a. [DOI] [PMC free article] [PubMed] [Google Scholar]